Rachel Patricia Moate

Title: Rachel Patricia Moate: Innovator in Rheumatoid Arthritis Biomarkers

Introduction

Rachel Patricia Moate is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of biomedical research, particularly in the area of rheumatoid arthritis. Her innovative work focuses on the development of clinical biomarkers that can enhance treatment outcomes for patients suffering from this chronic condition.

Latest Patents

Rachel holds a patent titled "Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis." This patent relates to the use of anti-PAD4 autoantibodies as a clinical biomarker for rheumatoid arthritis (RA) treatment. The disclosure further provides an assay to detect these autoantibodies, assay kits for their detection, as well as computer-implemented diagnostic methods. She has 1 patent to her name, showcasing her innovative approach to medical diagnostics.

Career Highlights

Rachel is currently employed at Medimmune Limited, where she continues to advance her research in immunology and biomarker development. Her work is pivotal in understanding the clinical implications of autoantibodies in rheumatoid arthritis, which can lead to more effective treatment strategies.

Collaborations

Rachel has collaborated with notable colleagues, including Alex Godwood and Ethan Grant. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in the field of rheumatoid arthritis.

Conclusion

Rachel Patricia Moate is a remarkable inventor whose work in the development of clinical biomarkers for rheumatoid arthritis is paving the way for improved patient care. Her contributions to the field are invaluable and highlight the importance of innovation in medical research.